Skip to content

Robert M. Jacobson, M.D.

NPI 1205915378ActiveIndividual· Colon & Rectal Surgery· Dallas, TX

Colon & Rectal Surgery (M.D.) in Dallas, Texas, licensed in TX, with an NPI issued in November 2006. Enrolled in Medicare as practitioner - colorectal surgery (proctology). Takeda Pharmaceuticals U.S.A., Inc. reported $24,042 in payments in 2025, mostly speaking and faculty fees.

Overview

NPI1205915378
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedNov 2, 2006
Last updated in NPPESMay 14, 2015

Specialties and licenses

TaxonomyCodeLicenseState
Colon & Rectal Surgery Primary208C00000XE3321TX
Specialist174400000X——

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Colorectal Surgery (Proctology) (TX)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$24,042 · 19 payments from 1 company
  • 2024$6,513 · 16 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Takeda Pharmaceuticals U.S.A., Inc.$24,04219

What the 2025 payments were for

  • Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$16,250 · 3 payments
  • Consulting Fee$5,417 · 1 payment
  • Travel and Lodging$1,967 · 8 payments
  • Food and Beverage$409.11 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other colorectal surgeons in Dallas

All 38 colorectal surgeons in Dallas · All colorectal surgeons in Texas